prednisone and Opportunistic Infections studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

Excerpt	Relevance	Reference
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections."	7.76	Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010)
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)."	6.76	Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011)
" Here, we present the case of a 40-year-old male with severe ileocecal-CD who developed a reactivation of dermatomal herpes zoster after treatment with prednisone and adalimumab."	4.89	Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease. ( Fedorak, RN; Ma, C; Walters, B, 2013)
" Clinical studies, registries, and case reports warn of the increased risk of infections, particularly opportunistic infections; however, already in the steroid monotherapy era, patients are at risk because it is accepted that a patient should be considered immunosuppressed when receiving a daily dose of 20 mg of prednisone for 2 weeks."	4.88	Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary. ( de Ridder, L; Dias, JA; Escher, JC; Fell, J; Kolacek, S; Koletzko, S; Malmborg, P; Misak, Z; Rahier, JF; Veereman-Wauters, G; Veres, G, 2012)
"MTX, TNF antagonists and prednisone at doses >10 mg daily were associated with increased risks of overall infections."	3.76	Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. ( Bishai, W; Greenberg, JD; Hochberg, MC; Kavanaugh, A; Kremer, JM; Reed, G; Tindall, E; Zheng, C, 2010)
" The authors report a case of histoplasmosis presenting with signs of severe hypercalcemia and renal failure in a patient on infliximab for approximately three years in combination with low dosages of methotrexate and prednisone."	3.76	Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy. ( Kamili, Qu; Menter, A, 2010)
" She had been receiving immunosuppressive therapy with methotrexate and prednisone for large-vessel vasculitis."	3.76	Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. ( Battegay, M; Trendelenburg, M; Vetter, M, 2010)
" In our patient, both polymyositis and steroid therapy were predisposing factors of cutaneous leishmaniasis onset; prednisone therapy has been postulated to be associated with immune dysfunction leading to: reduced blood T cells' levels (CD4 et CD8) as well as decreased cytokine synthesis (e."	3.73	[Cutaneous leishmaniasis in polymyositis]. ( Bernet, J; Courville, P; Favennec, L; Fevre, C; Levesque, H; Marie, I, 2006)
" After two weeks of prednisone therapy, the patient developed prolonged fever, which was caused by CMV disseminated disease, with prompt clinical recovery after ganciclovir administration."	3.72	Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. ( Aoki, V; Casals, DS; Correa, MC; Leite, OH; Maruta, CW; Nunes, Ede A; Rivitti, EA; Santi, CG; Simonsen Nico, MM, 2003)
" A 52 year old woman is reported who was on long term treatment with chlorambucil and taking a short course of prednisone for familial CLL before she developed progressive dyspnoea, and P carinii pneumonia was diagnosed in bronchoalveolar lavage fluid."	3.72	Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. ( Halter, J; Hechelhammer, L; Himmelmann, A; Vavricka, SR, 2004)
"Hypertension develops in most patients after transplantation when immunosuppression is based on cyclosporine and prednisone."	3.68	De novo hypertension after liver transplantation. ( Textor, SC, 1993)
" He had the nephrotic syndrome for which he was on 60 mg prednisone daily."	3.68	Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole. ( Coley, KE; Duffill, MB, 1993)
"Seventeen cases of pneumonia occurring in renal transplantation patients treated with cyclosporine-prednisone immunosuppression were analyzed with regard to the organisms involved, time of occurrence after transplantation, clinical course, and radiographic findings."	3.67	Pulmonary infections in renal transplantation patients treated with cyclosporine. ( Amend, WJ; Moore, EH; Webb, WR, 1988)
"Newly diagnosed patients with multiple myeloma (MM) (n=122) aged greater than 55 yr, not eligible for transplantation were randomized to receive 8 cycles of M (9 mg/m(2) /d) and P (60 mg/m(2) /d) for 4d every 6 wk (n=62) or MP and thalidomide (100 mg/d) continuously (n=60)."	2.76	Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. ( Ali, R; Aydogdu, I; Beksac, M; Firatli-Tuglular, T; Goker, H; Gulbas, Z; Haznedar, R; Karakus, S; Kaya, E; Kaygusuz, I; Konuk, N; Ozdogu, H; Ozet, G; Sucak, G; Undar, L, 2011)
"Nocardiosis is an uncommon opportunistic infection seen in immunocompromised patients or those with a dysfunctional immune system."	2.72	Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review. ( Chen, C; Chen, M; He, Y; Li, X; Liang, M; Liu, S; Luo, N; Singh, S; Tan, S; Yang, W, 2021)
"MPA Cpredose and MPA AUC are significantly related to the incidence of biopsy-proven rejection after kidney transplantation, whereas MMF dose is significantly related to the occurrence of adverse events."	2.69	A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. ( de Fijter, JW; Hale, MD; Hené, RJ; Hilbrands, LB; Navarro, MT; Nicholls, AJ; Squifflet, JP; van Gelder, T; Vanrenterghem, Y; Verpooten, GA; Weimar, W, 1999)
"Evans syndrome is a rare disorder characterized by combined autoimmune thrombocytopenia (ITP) and autoimmune hemolytic anemia (AIHA)."	2.41	Allogeneic stem cell transplantation for Evans syndrome. ( Burt, RK; Miranda, M; Oyama, Y; Papadopoulos, EB; Traynor, AE, 2001)
"A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology."	2.38	[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991)
"Although rabbit anti-thymocyte globulin (rATG) is commonly used as induction therapy for kidney transplantation, dosing is not standardized."	1.42	Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. ( Lee, E; Lee, S; Park, JM; Pennington, CA; Sindelar, J; Tischer, SM, 2015)
"These infections included four cases of pneumocystosis, two cases of candidiasis, two cases of aspergillosis, two cases of cryptococcosis and one case of mucormycosis."	1.39	Invasive fungal infections in renal transplant recipients: about 11 cases. ( Ayadi, A; Charffedine, K; Cheikhrouhou, F; Guidara, R; Hachicha, J; Makni, F; Néji, S; Sellami, H; Trabelsi, H; Yaich, S, 2013)
"Crusted Norwegian scabies is an extremely rare hyperkeratotic variant of scabies infestation."	1.37	Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis. ( Aractingi, S; Baccouche, K; Berenbaum, F; Guegan, S; Sellam, J, 2011)
"We report on a patient with Pneumocystis jirovecii pneumonia who developed fever, rash, eosinophilia and hepatitis 10 days after initiation of a therapy with sulfamethoxazole and trimethoprim."	1.36	[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)]. ( Derungs, A; Kummer, O; Rätz Bravo, AE, 2010)
"Kaposi's sarcoma is a vascular tumor caused by human herpesvirus-8 infection."	1.36	Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis. ( de Francisco, R; Fernández-García, MS; García-Pravia, C; Gutiérrez-Corral, N; Riestra, S; Rodrigo, L; Rodríguez, JI; Rodríguez-Peláez, M, 2010)
"She simultaneously developed pulmonary nocardiosis as well as a soft tissue infection and osteomyelitis by mycobacterium abscessus."	1.35	[Pulmonary nodules in a patient on long-term steroid treatment]. ( Bürgi, U; Hurni, Ch; Perrig, M; Rauch, A; Schoenenberger, AW; Trost, N, 2008)
"We present a patient with chronic lymphocytic leukemia who died from Pneumocystis pneumonia (PCP) despite appropriate anti-Pneumocystis therapy."	1.35	Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. ( Kovacs, JA; Masur, H, 2009)
"Strongyloidiasis is epidemic in tropical and subtropical regions where the regional prevalence may exceed 25%."	1.34	Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. ( Dincer, HE; Krishnamurthy, R; Whittemore, D, 2007)
" Diagnosis was based on the very typical ocular feature combined with a positive blood or vitreous culture."	1.33	[Endogenous Candida endophthalmitis combined with severe general diseases]. ( Stoffelns, BM, 2005)
"Lymphocytopenia has been reported in patients with connective tissue diseases, including dermatomyositis (DM)."	1.32	Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. ( Bachelez, H; de la Salmonière, P; Dubertret, L; Fouéré, S; Lebbe, C; Morel, P; Rabian, C; Viguier, M, 2003)
"A 48 year old patient with active Crohn's disease presented with bilateral nodules over his lungs resembling malignant metastasis."	1.32	Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. ( Majoor, CJ; Schreurs, AJ; Weers-Pothoff, G, 2004)
"The other patient presented with upper gastrointestinal hemorrhage from a bleeding duodenal ulcer."	1.31	[Atypical cytomegalovirus in renal transplantation: a new form of presentation]. ( Campistol, JM; Cofán, F; Esforzado, N; Llach, J; Oppenheimer, F; Pérez-Valentín, MA; Solé, M, 2002)
" Despite prompt initiation of antimycotic therapy the outcome was fatal; dosage of conventional and liposomal amphotericin B was limited due to treatment-related toxicities."	1.31	A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. ( Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K, 2001)
"We describe the clinical presentation, treatment of Kaposi's sarcoma skin lesions in an immunosuppressed patient with bullous pemphigoid."	1.30	Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. ( Gaspari, AA; Marchese, S; Powell, D; Rady, PL; Tyring, SK, 1997)
"402 patients with chronic lymphocytic leukemia not previously treated or treated with chlorambucil (with or without prednisone) who received fludarabine (30 mg/m2 of body surface area per day for 5 days) with or without prednisone at 4-week intervals."	1.30	Infections in patients with chronic lymphocytic leukemia treated with fludarabine. ( Anaissie, EJ; Kantarjian, H; Keating, MJ; Kontoyiannis, DP; Lerner, S; O'Brien, S; Robertson, L, 1998)
"Disseminated histoplasmosis is an unusual complication in endemic areas and has been reported in patients with an immunodeficient state, either from human immunodeficiency virus (HIV) infection or transplantation."	1.30	Disseminated histoplasmosis and Wegener's granulomatosis. ( Manepalli, AN; Rush, L, 1998)
"A patient with systemic lupus erythematosus (SLE) developed primary subcutaneous nocardiosis during steroid and cyclophosphamide therapy for diffuse proliferative glomerulonephritis."	1.30	Primary subcutaneous nocardial infection in a SLE patient. ( Balbir-Gurman, A; Nahir, AM; Schapira, D, 1999)
"We report the first case of nocardiosis in a recently transplanted renal patient maintained on tacrolimus, prednisone, and mycophenolate mofetil."	1.30	Nocardiosis in a recently transplanted renal patient. ( Holley, JL; Reddy, SS, 1998)
"Although infectious esophagitis is usually due to infection with Candida, herpes virus, or cytomegalovirus, bacterial esophagitis is occasionally observed."	1.29	Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment. ( Orchard, JL; Richert, SM, 1995)
"The primary skin lesion of pemphigus vulgaris which was often fatal before the introduction of systemic glucocorticoid therapy, is a flaccid, fragile blister which can occur anywhere."	1.29	Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris. ( Takeshita, T, 1996)
"Most aspects of Wegener granulomatosis were similar in childhood-onset and adult-onset patients."	1.29	Wegener granulomatosis in children and adolescents: clinical presentation and outcome. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, R; Rottem, M, 1993)
"A further case of listeriosis has recently been described in a man who developed the infection 2 years after successful fludarabine treatment while he had a normal CD4 lymphocyte count."	1.29	Late listeriosis after fludarabine plus prednisone treatment. ( Girmenia, C; Mauro, FR; Rahimi, S, 1994)
"carinii pneumonia in patients with Wegener's granulomatosis."	1.29	Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. ( Fauci, AS; Hoffman, GS; Kerr, GS; Leavitt, RY; Ognibene, FP; Reda, D; Shelhamer, JH, 1995)
"Proven Pneumocystis carinii pneumonia (PCP) occurred in 8 (5."	1.29	Pneumocystis carinii pneumonia after liver transplantation in adults. ( Hayes, MJ; McCaughan, GW; Sheil, AG; Torzillo, PJ, 1994)
"We report a 49 years old woman with systemic lupus erythematosus and a WHO type IV nephropathy, treated with prednisone 1 mg/kg/day po and cyclophosphamide 1 g/month iv."	1.29	[Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia]. ( Guzmán, L; Neira, O; Wainstein, E, 1993)
"Temporal arteritis is a systemic necrotizing vasculitis for which the only effective treatment is systemic corticosteroids."	1.29	Invasive aspergillosis. A complication of treatment of temporal arteritis. ( Wiggins, RE, 1995)
"Children with malignancy have a high incidence of pneumonia and pneumonitis and death is rare if the patient does not have terminal malignant disease."	1.28	Pneumonia and pneumonitis in childhood malignancy. ( Eden, OB; Elton, R; Shaw, NJ, 1992)
"Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)."	1.28	Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991)
"The course of Wegener granulomatosis has been dramatically improved by daily treatment with cyclophosphamide and glucocorticoids."	1.28	Wegener granulomatosis: an analysis of 158 patients. ( Fauci, AS; Hallahan, CW; Hoffman, GS; Kerr, GS; Leavitt, RY; Lebovics, RS; Rottem, M; Travis, WD, 1992)
"Six had systemic lupus erythematosus and another had dermatomyositis and are described in detail."	1.28	Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. ( Alarcón-Segovia, D; Guerra-Bautista, G; Kraus, A, 1991)

Research

Studies (123)

Authors

Clinical Trials (19)

Trial Overview

Trial Outcomes

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Deaths

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (5.69)	18.7374
1990's	45 (36.59)	18.2507
2000's	37 (30.08)	29.6817
2010's	29 (23.58)	24.3611
2020's	5 (4.07)	2.80

Authors	Studies
Shah, NJ	1
Cook, MR	1
Wu, T	1
Lev-Ari, S	1
Blackburn, MJ	1
Serzan, MT	1
Alaoui, A	1
Ahn, J	1
Atkins, MB	1
Braud, A	1
Wurth, S	1
Leblanc, S	1
Mahé, A	1
Serrano, OK	1
Kutzler, HL	1
Rochon, C	1
Radojevic, JA	1
Lawlor, MT	1
Hammond, JA	1
Gluck, J	1
Feingold, AD	1
Jaiswal, A	1
Wang, H	1
Zhao, Y	1
Zhang, X	1
Si, X	1
Song, P	1
Xiao, Y	1
Yang, X	1
Song, L	1
Shi, J	1
Zhao, H	1
Zhang, L	1
Luo, N	1
Tan, S	1
Li, X	1
Liu, S	1
Singh, S	1
Chen, M	1
Yang, W	1
He, Y	1
Chen, C	1
Liang, M	1
Dameron, M	1
Horowitz, M	1
Gupta, N	1
Abi Hatem, N	1
Garner, O	1
Ramirez-Berlioz, A	1
Iardino, A	1
Mocherla, S	1
Bhairavarasu, K	1
Mahajan, KR	1
Kobayashi, T	1
Ford, B	1
Sekar, P	1
Ma, C	1
Walters, B	1
Fedorak, RN	1
Trabelsi, H	1
Néji, S	1
Sellami, H	1
Yaich, S	1
Cheikhrouhou, F	1
Guidara, R	1
Charffedine, K	1
Makni, F	1
Hachicha, J	1
Ayadi, A	1
Lauten, M	1
Güttel, C	1
Härtel, C	1
Erdlenbruch, B	1
Garrido Colmenero, C	1
Arias Santiago, S	1
Blasco Morente, G	1
Martín Castro, A	1
Leshem, YA	1
Gdalevich, M	1
Ziv, M	1
David, M	1
Hodak, E	1
Mimouni, D	1
Malkan, AD	1
Wahid, FN	1
Rao, BN	1
Sandoval, JA	1
Pennington, CA	1
Tischer, SM	1
Lee, E	1
Lee, S	1
Sindelar, J	1
Park, JM	1
Matschke, J	1
Müller-Beissenhirtz, H	1
Novotny, J	1
Vester, I	1
Hertenstein, B	1
Eisele, L	1
Lax, H	1
Ose, C	1
Dührsen, U	1
Hurni, Ch	1
Rauch, A	1
Trost, N	1
Perrig, M	1
Bürgi, U	1
Schoenenberger, AW	1
Khellaf, M	1
Godeau, B	2
Rubia, MF	1
Chozas, N	1
García-Martos, P	1
Reyes, F	1
Greenberg, JD	1
Reed, G	1
Kremer, JM	1
Tindall, E	1
Kavanaugh, A	1
Zheng, C	1
Bishai, W	1
Hochberg, MC	1
Cerceo, E	1
Kotloff, RM	1
Hadjiliadis, D	1
Ahya, VN	1
Pochettino, A	1
Gillespie, C	1
Christie, JD	1
Kovacs, JA	1
Masur, H	1
Jurawan, R	1
de Almeida, M	1
Smith, A	1
Weilert, F	1
Isenberg, D	1
Appel, GB	1
Contreras, G	1
Dooley, MA	1
Ginzler, EM	1
Jayne, D	1
Sánchez-Guerrero, J	1
Wofsy, D	1
Yu, X	1
Solomons, N	1
Kamili, Qu	1
Menter, A	1
Vetter, M	1
Battegay, M	1
Trendelenburg, M	1
Bonnet, N	1
Guis, S	1
Drancourt, M	1
Brouqui, P	1
Berbis, P	1
Derungs, A	1
Rätz Bravo, AE	1
Kummer, O	1
Beksac, M	1
Haznedar, R	2
Firatli-Tuglular, T	1
Ozdogu, H	1
Aydogdu, I	1
Konuk, N	1
Sucak, G	1
Kaygusuz, I	1
Karakus, S	1
Kaya, E	1
Ali, R	1
Gulbas, Z	1
Ozet, G	1
Goker, H	1
Undar, L	1
Rodríguez-Peláez, M	1
Fernández-García, MS	1
Gutiérrez-Corral, N	1
de Francisco, R	1
Riestra, S	1
García-Pravia, C	1
Rodríguez, JI	1
Rodrigo, L	1
Baccouche, K	1
Sellam, J	1
Guegan, S	1
Aractingi, S	1
Berenbaum, F	1
Efthimiou, P	1
Pokharna, H	1
Kukar, M	1
Hennessey, K	1
Hemmaway, C	1
Laverse, E	1
Nicholas, M	1
Nagy, Z	1
Dai, W	1
Dharamsi, JW	1
Soliman, S	1
Ricotti, C	1
Gander, R	1
Bergstresser, P	1
Chan, J	1
Kaswan, KK	1
Vanikar, AV	1
Feroz, A	1
Patel, HV	1
Gumber, M	1
Trivedi, HL	1
Li, F	1
Jin, HZ	1
Su, F	1
Jia, L	1
Sun, QN	1
Veereman-Wauters, G	1
de Ridder, L	1
Veres, G	1
Kolacek, S	1
Fell, J	1
Malmborg, P	1
Koletzko, S	1
Dias, JA	1
Misak, Z	1
Rahier, JF	1
Escher, JC	1
Kim, T	1
Choi, SH	1
Kim, SH	1
Jeong, JY	1
Woo, JH	1
Kim, YS	1
Sung, H	1
Kim, MN	1
Yoon, DH	1
Suh, C	1
Lee, SO	1
Williams, MS	1
Ali, N	1
Nonaka, D	1
Bloor, AJ	1
Somervaille, TC	1
MacMillan, ML	1
Weisdorf, DJ	1
Wagner, JE	1
DeFor, TE	1
Burns, LJ	1
Ramsay, NK	1
Davies, SM	1
Blazar, BR	1
Pérez-Valentín, MA	1
Cofán, F	1
Solé, M	1
Llach, J	1
Esforzado, N	1
Campistol, JM	1
Oppenheimer, F	1
Jastrzembski, SA	1
Teirstein, AS	1
Herman, SD	1
DePalo, LR	1
Lento, PA	1
Krebs, M	1
Watschinger, B	1
Brunner, C	1
Hassl, A	1
Base, W	1
Seifert, B	1
Favre, G	1
Viguier, M	1
Fouéré, S	1
de la Salmonière, P	1
Rabian, C	1
Lebbe, C	1
Dubertret, L	1
Morel, P	1
Bachelez, H	1
Casals, DS	1
Nunes, Ede A	1
Maruta, CW	1
Aoki, V	1
Santi, CG	1
Simonsen Nico, MM	1
Correa, MC	1
Leite, OH	1
Rivitti, EA	1
Gentil, B	1
Cottin, V	1
Girard, P	1
Cordier, JF	1
Vavricka, SR	1
Halter, J	1
Hechelhammer, L	1
Himmelmann, A	1
Suárez Ortega, S	1
Campos-Herrero Navas, MI	1
Limeres González, MA	1
Díaz López, F	1
Zarzalejos Andes, JM	1
Arkuch Saade, ME	1
Majoor, CJ	1
Schreurs, AJ	1
Weers-Pothoff, G	1
Arunkumar, P	1
Crook, T	1
Ballard, J	1
Tanaka, Y	1
Singh, SM	1
Rau, NV	1
Cohen, LB	1
Harris, H	1
Stoffelns, BM	1
Baughman, RP	2
Lower, EE	1
Kalkanci, A	1
Kokturk, N	1
Senol, E	1
Acar, K	1
Guzel, O	1
Sancak, B	1
Kustimur, S	1
Rowin, J	1
Amato, AA	1
Deisher, N	1
Cursio, J	1
Meriggioli, MN	1
Marie, I	1
Fevre, C	1
Favennec, L	1
Courville, P	1
Bernet, J	1
Levesque, H	1
Riera-Mestre, A	1
de la Haba-Vacas, I	1
Vidaller-Palacín, A	1
Fernández-Viladrich, P	1
Krishnamurthy, R	1
Dincer, HE	1
Whittemore, D	1
Ekberg, H	1
Tedesco-Silva, H	1
Demirbas, A	1
Vítko, S	1
Nashan, B	1
Gürkan, A	1
Margreiter, R	1
Hugo, C	1
Grinyó, JM	1
Frei, U	1
Vanrenterghem, Y	2
Daloze, P	1
Halloran, PF	1
Peacock, JE	1
Greven, CM	1
Cruz, JM	1
Hurd, DD	1
Faulk, CT	1
Lesher, JL	1
Sneller, MC	1
Hoffman, GS	4
Talar-Williams, C	1
Kerr, GS	4
Hallahan, CW	3
Fauci, AS	4
Wiggins, RE	1
Richert, SM	1
Orchard, JL	1
Hayes, MJ	1
Torzillo, PJ	1
Sheil, AG	1
McCaughan, GW	1
Ognibene, FP	1
Shelhamer, JH	1
Reda, D	1
Leavitt, RY	3
Scalzini, A	1
Barni, C	1
Stellini, R	1
Sueri, L	1
Gehrke, D	1
Herzum, M	1
Schönian, U	1
Klein, HH	1
Drude, L	1
Mennel, HD	1
Maisch, B	1
Girmenia, C	1
Mauro, FR	1
Rahimi, S	1
Peral, V	1
Vidau, P	1
Herrera, J	1
Rodriguez, C	1
Tricas, L	1
Tomé, R	1
Arroyo, F	1
Fang, J	1
Viksman, MY	1
Ebisawa, M	1
Bochner, BS	1
Machet, MC	1
Stephanov, E	1
Estève, E	1
De Closets, F	1
Barrabès, A	1
Thérizol-Ferly, M	1
Lebret, G	1
Grangeponte, MC	1
Vaillant, L	1
Schaller, J	1
Rohwedder, A	1
Breier, B	1
Werchau, H	1
Wainstein, E	1
Neira, O	1
Guzmán, L	1
Coutant-Perronne, V	1
Le Thi Huong, D	1
Guillevin, L	1
Magadur, G	1
De Bandt, M	1
Dellion, S	1
Rossert, J	1
Rostoker, G	1
Piette, JC	1
Textor, SC	1
Rottem, M	2
Lebovics, R	1
Duffill, MB	1
Coley, KE	1
Shield, CF	1
Jacobs, RJ	1
Wyant, S	1
Das, A	1
Takeshita, T	1
Hedderwick, SA	1
Bonilla, HF	1
Bradley, SF	1
Kauffman, CA	1
Gaspari, AA	1
Marchese, S	1
Powell, D	1
Rady, PL	1
Tyring, SK	1
Mookerjee, BP	1
Vogelsang, G	1
Mohammedi, I	1
Vedrinne, JM	1
Floccard, B	1
Reverdy, ME	1
Duperret, S	1
Motin, J	1
Pareja, JG	1
Garland, R	1
Koziel, H	1
Poveda, F	1
García-Alegría, J	1
de las Nieves, MA	1
Villar, E	1
Montiel, N	1
del Arco, A	1
Reddy, SS	1
Holley, JL	1
Anaissie, EJ	1
Kontoyiannis, DP	1
O'Brien, S	1
Kantarjian, H	1
Robertson, L	1
Lerner, S	1
Keating, MJ	1
Sarmiento, JM	1
Munn, SR	1
Paya, CV	1
Velosa, JA	1
Nguyen, JH	1
Manepalli, AN	1
Rush, L	1
Schnader, J	1
Pina, EM	1
Glassroth, J	1
Adebonojo, S	1
Wang, BY	1
Krishnan, S	1
Isenberg, HD	1
Balbir-Gurman, A	1
Schapira, D	1
Nahir, AM	1
van Gelder, T	1
Hilbrands, LB	1
Weimar, W	1
de Fijter, JW	1
Squifflet, JP	1
Hené, RJ	1
Verpooten, GA	1
Navarro, MT	1
Hale, MD	1
Nicholls, AJ	1
Tirelli, U	2
Vaccher, E	2
Spina, M	1
Carbone, A	1
Martel, J	1
Faisant, M	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Studies of Human Pneumocystis Infection[NCT00342589]		1,500 participants (Anticipated)	Observational	1999-09-28	Recruiting
A Prospective, Randomized, Active Controlled, Parallel Group, Multi-center Trial to Assess the Efficacy and Safety of Mycophenolate Mofetil (MMF) in Inducing Response and Maintaining Remission in Subjects With Lupus Nephritis.[NCT00377637]	Phase 3	370 participants (Actual)	Interventional	2005-07-31	Completed
Phase III Trial Comparing Treatment With Melphalan+Prednisolon (MP) With Melphalan+Prednisolon+Thalidomide (MPT) for Previously Untreated Elderly Patients With Multiple Myeloma[NCT00934154]	Phase 3	122 participants (Actual)	Interventional	2006-03-31	Completed
A Pilot Study on the Efficacy of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive by Next Generation Flow[NCT03992170]	Phase 2	50 participants (Anticipated)	Interventional	2018-12-31	Recruiting
A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for[NCT05218603]		100 participants (Anticipated)	Observational	2021-11-30	Recruiting
Development and Validation of New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma in CYP3A5 Expressors and Non-Expressors[NCT04657562]		380 participants (Anticipated)	Observational [Patient Registry]	2020-08-01	Recruiting
Evaluating Safety and Efficacy of MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Combination With Low-Dose CsA, Tac or Sir in Comparison to Current Standard Immunosuppression (MMF, CsA and Corticosteroids) in Renal Tx[NCT00231764]	Phase 4	1,760 participants	Interventional	2002-11-30	Completed
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma: a Randomized Controlled Trial[NCT04448873]	Phase 4	30 participants (Actual)	Interventional	2020-07-01	Completed
A Staged Therapeutic Approach Using Cyclophosphamide and Methotrexate in the Treatment of Wegener's Granulomatosis and Related Vasculitides[NCT00001473]		100 participants	Observational	1995-03-31	Completed
An Open Trial of the Efficacy of Glucocorticoids and Methotrexate (MTX) in the Treatment of Systemic Vasculitis[NCT00001256]	Phase 2	100 participants	Interventional	1990-03-31	Completed
Pilot Trial for Implementation of a MPA PK Monitoring Strategy[NCT00187915]		24 participants (Actual)	Interventional	2003-07-31	Completed
An Open, Prospective, Randomised, Controlled, Multi-Center Study Comparing Fixed Dose vs Concentration Controlled Mycophenolate Mofetil Regimens for de Novo Patients Following Transplantation[NCT00166244]	Phase 4	901 participants (Actual)	Interventional	2003-05-31	Completed
An Open Label Pilot Study Examining the Use of Rituximab in Patients With Wegener's Granulomatosis Who Have Experienced Disease Relapse on Standard Therapies[NCT00072592]	Phase 1	10 participants	Interventional	2003-10-31	Completed
Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis[NCT02626845]	Phase 4	3 participants (Actual)	Interventional	2015-12-31	Terminated (stopped due to Slow recruitment)
Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis[NCT00001761]	Phase 1	15 participants	Interventional	1998-02-28	Completed
Treatment of Wegener's Granulomatosis With Cyclophosphamide[NCT00001155]	Phase 2	200 participants	Interventional	1976-02-29	Completed
Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides. A Randomized Controlled Trial.[NCT00751517]	Phase 2	0 participants	Interventional		Active, not recruiting
A Randomized Trial Comparing Methotrexate Versus Mycophenolate Mofetil for Remission Maintenance in Wegener's Granulomatosis and Related Vasculitides[NCT00004567]	Phase 2	75 participants	Interventional	2000-02-29	Completed
Phase I/II Trial of TNFR:Fc (Etanercept) in Patients With Wegener's Granulomatosis[NCT00001901]	Phase 2	60 participants	Interventional	1999-02-28	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Treatment Failure was adjudicated by a clinical endpoints committee (CEC) and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis (LN). (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Participants With End-stage Renal Disease (ESRD)

Intervention	Deaths (Number)
Mycophenolate Mofetil (MMF)	0
Azathioprine (AZA)	1

Time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), was defined as any 1 the following: death, ESRD, sustained doubling of serum creatinine, renal flare (proteinuric or nephritic), or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. ESRD is defined as progression to chronic hemodialysis or renal transplant. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Maintenance Phase: Events Contributing to the Primary Endpoint: Number of Participants With Sustained Doubling of Serum Creatinine

Intervention	participants (Number)
Mycophenolate Mofetil (MMF)	0
Azathioprine (AZA)	3

Sustained doubling of serum creatinine concentration is defined as the first serum creatinine value that is twice the mean of the lowest 2 values from screening to end of induction, as confirmed by a second serum creatinine value obtained at least 4 weeks after the initial doubling. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Maintenance Phase: Participants With Major Extra-renal Flare

Intervention	participants (Number)
Mycophenolate Mofetil	1
Azathioprine	5

A major extra-renal flare is defined as a British Isles Lupus Assessment Group (BILAG) Score category A in one extrarenal organ or three organs with concurrent category B scores. BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Induction Phase: Change From Baseline in Short-Form Health Survey (SF-36) Domain and Component Scores

Intervention	participants (Number)
Mycophenolate Mofetil	7
Azathioprine	6

The SF-36 is a 36 item quality of life questionnaire. The short-form version has eleven questions that permit the participant to rate how they feel that particular day. The SF-36 consists of eight scaled scores and two component scores, which are the weighted sums of the questions in their section. Each scale is directly transformed into a 0-100 score with the higher scores indicating better quality of life. (NCT00377637)
Timeframe: Baseline and 24 weeks

Induction Phase: Change From Baseline to Week 24 in 24-hour Urine Protein

Intervention	Scores on a scale (Mean)
	Physical Component Summary [n=139, 137]	Mental Component Summary [n=139, 137]	Bodily Pain Score [n=141, 137]	General Health Score [n=139, 137]	Mental Health Score [n=141, 137]	Physical functioning Score [n=141, 137]	Role-Emotional Score [n=141, 137]	Role-Physical Score [n=141, 137]	Social Function Score [n=141, 137]	Vitality Score [n=141, 137]
Intravenous Cyclophosphamide	6.4	5.7	16.8	11.5	9.8	9.3	18.4	34.0	18.2	11.6
Mycophenolate Mofetil	5.2	6.7	13.4	9.1	9.3	11.6	23.4	28.6	17.7	14.2

24-hour urine protein was measured at Baseline and Week 24. (NCT00377637)
Timeframe: Baseline, Week 24

Induction Phase: Change From Baseline to Week 24 in Serum Albumin

Induction Phase: Change From Baseline to Week 24 in Serum Creatinine

Induction Phase: Change in Renal British Isles Lupus Assessment Group (BILAG) Score

Intervention	mg/day (Mean)
	Baseline [n=180, 180]	Week 24 [n= 150, 144]	Change from Baseline to Week 24 [n= 146, 142]
Intravenous Cyclophosphamide	4451.4	1831.6	-2513.7
Mycophenolate Mofetil	4208.9	1599.0	-2510.6

Intervention	g/L (Mean)
	Baseline [n=184, 185]	Week 24 [n=155, 151]	Change from Baseline to Week 24 [n=154, 151]
Intravenous Cyclophosphamide	28.6	38.3	9.0
Mycophenolate Mofetil	30.5	38.4	7.5

Intervention	µmol/L (Mean)
	Baseline [n= 184, 185]	Week 24 [n= 155, 151]	Change from Baseline to Week 24 [n= 154, 151]
Intravenous Cyclophosphamide	92.7	83.5	-5.1
Mycophenolate Mofetil	108.6	77.6	-18.9

"BILAG indices provide a scoring system for the assessment of lupus disease activity in terms of the need for steroid treatment in 8 organs/systems. Eighty-six items were scored resulting in a classification of A (severe activity), B (moderate activity), C (mild activity), D (no current activity) and E (no activity ever observed) for each organ system. The BILAG individual system summaries were calculated by a program supplied by ADS-Limathon (Sheffield, UK).~The score at baseline was compared to the score at the 24 week endpoint for each treatment group, reported here for the renal system." (NCT00377637)
Timeframe: Baseline, 24 weeks

Induction Phase: Number of Participants Achieving Complete Remission

Intervention	Percentage of participants (Number)
	Shift from Baseline=A to 24 Week Endpoint=A	Shift from Baseline=A to 24 Week Endpoint=B	Shift from Baseline=A to 24 Week Endpoint=C	Shift from Baseline=A to 24 Week Endpoint=D	Shift from Baseline=B to 24 Week Endpoint=A	Shift from Baseline=B to 24 Week Endpoint=B	Shift from Baseline=B to 24 Week Endpoint=C	Shift from Baseline=B to 24 Week Endpoint=D	Shift from Baseline=C to 24 Week Endpoint=A	Shift from Baseline=C to 24 Week Endpoint=B	Shift from Baseline=C to 24 Week Endpoint=C	Shift from Baseline=C to 24 Week Endpoint=D	Shift from Baseline=D to 24 Week Endpoint=A	Shift from Baseline=D to 24 Week Endpoint=B	Shift from Baseline=D to 24 Week Endpoint=C	Shift from Baseline=D to 24 Week Endpoint=D
Intravenous Cyclophosphamide	27.1	34.8	24.9	9.4	0.0	1.1	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.6	0.0
Mycophenolate Mofetil	17.1	39.2	33.1	5.5	0.0	1.7	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0

Number of participants achieving complete remission as defined by return to normal serum creatinine, proteinuria ≤500 mg/24 hours and an inactive urinary sediment (absence of red blood cells, white blood cells or cellular or granular casts) after 24 weeks. (NCT00377637)
Timeframe: 24 weeks

Induction Phase: Number of Patients Showing Treatment Response

Intervention	participants (Number)
	Complete Remission - Yes	Complete Remission - No
Intravenous Cyclophosphamide	15	170
Mycophenolate Mofetil	16	169

Treatment response was adjudicated by a blinded clinical endpoints committee (CEC) and defined as: a) Decrease in proteinuria, defined as a decrease in the urine protein to creatinine ratio (UPCr) to <3 in subjects with baseline proteinuria ≥3 UPCr or a decrease in the UPCr by ≥50% in subjects with proteinuria <3 UPCr at Baseline, and b) Stabilization of serum creatinine or improvement. UPCr were derived from the 24 hour urine collection. Patients who did not show a treatment response at Week 24 or who withdrew earlier than Week 24 were considered non-responders. (NCT00377637)
Timeframe: 24 weeks

Maintenance Phase: Events Contributing to the Primary Endpoint: Kaplan-Meier Estimates of Percentage of Participants Not Receiving Rescue Therapy

Intervention	participants (Number)
	Responder	Non-responder
Intravenous Cyclophosphamide	98	87
Mycophenolate Mofetil	104	81

The primary efficacy parameter was the time to treatment failure, adjudicated by the Clinical Endpoints Committee (CEC), defined as any of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or requirement for rescue therapy to treat deterioration or exacerbation of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to rescue treatment for each patient. The data presented are the percentage of participants who were rescue treatment free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Maintenance Phase: Events Contributing to the Primary Endpoint: Kaplan-Meier Estimates of Percentage of Participants Renal Flare Free, by Time Interval

Intervention	Percentage of participants (Number)
	Start of Maintenance Phase to Month 3	Month 3 to Month 6	Month 6 to Month 9	Month 9 to Month 12	Month 12 to Month 15	Month 15 to Month 18	Month 18 to Month 21	Month 21 to Month 24	Month 24 to Month 27	Month 27 to Month 30	Month 30 to Month 33	Month 33 to Month 36
Azathioprine	99.1	95.1	93.0	91.9	88.4	87.1	83.1	83.1	81.7	80.3	78.8	75.9
Mycophenolate Mofetil	100	98.2	97.2	94.2	94.2	94.2	93.1	91.9	90.8	90.8	90.8	90.8

A proteinuric flare is defined as a doubling of the urine protein:creatinine ratio, and proteinuria ≥1 g/24 h in patients with urine protein ≤0.5 g/24 h at the end of the induction phase, or proteinuria ≥2 g/24 h if urine protein was >0.5 g/24 h at the end of the induction phase. A nephritic flare is defined as a 25% increase in serum creatinine accompanied by 1 or more of the following: (a) simultaneous doubling of the proteinuria reaching a minimum of 2 g/24 h (b) new/increased hematuria or (c) the appearance of cellular casts. All flares were adjudicated by a clinical endpoints committee. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Maintenance Phase: Kaplan-Meier Estimates of Percentage of Participants Treatment Failure Free, by Time Interval

Intervention	Percentage of participants (Number)
	Start of Maintenance Phase to Month 3	Month 3 to Month 6	Month 6 to Month 9	Month 9 to Month 12	Month 12 to Month 15	Month 15 to Month 18	Month 18 to Month 21	Month 21 to Month 24	Month 24 to Month 27	Month 27 to Month 30	Month 30 to Month 33	Month 33 to Month 36
Azathioprine	97.2	90.3	87.2	85.0	82.8	79.2	78.0	75.5	74.2	74.2	72.9	70.1
Mycophenolate Mofetil	98.2	94.6	90.8	87.8	87.8	86.8	86.8	86.8	86.8	86.8	85.6	85.6

Treatment Failure was adjudicated by a clinical endpoints committee and was defined as the time to the earliest occurrence of any one of the following: death, end stage renal disease, sustained doubling of serum creatinine, renal flare, or a requirement for rescue therapy for exacerbation or deterioration of Lupus nephritis. Kaplan-Meier survival curves were estimated from the observed time to treatment failure for each patient. The data presented are the percentage of participants who were treatment-failure free at each time interval as estimated by Kaplan-Meier. (NCT00377637)
Timeframe: From the start of the Maintenance Phase to Month 36

Article	Year
Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review. BMC infectious diseases, 2021, Jan-06, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Humans; Immunocompromised Host; Male; Middle Ag	2021
Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn's disease. World journal of gastroenterology, 2013, Jun-07, Volume: 19, Issue:21 Topics: Acyclovir; Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal, Humanized; Antiviral	2013
Risk of infection and prevention in pediatric patients with IBD: ESPGHAN IBD Porto Group commentary. Journal of pediatric gastroenterology and nutrition, 2012, Volume: 54, Issue:6 Topics: Antibodies, Monoclonal; Drug Therapy, Combination; Europe; Humans; Immunosuppressive Agents; Inflamm	2012
[Corticosteroid therapy for nephrotic syndrome]. Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62, Issue:10 Topics: Drug Resistance; Drug Therapy, Combination; Femur Head Necrosis; Fractures, Spontaneous; Humans; Imm	2004
Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? Bone marrow transplantation, 1995, Volume: 15, Issue:6 Topics: Animals; Antibodies, Protozoan; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents	1995
Increased circulating levels of interleukin-5 in a case of steroid-resistant hypereosinophilic syndrome with ileal involvement. Longcope Firm of the Osler Housestaff. The Journal of allergy and clinical immunology, 1994, Volume: 94, Issue:1 Topics: Adult; Antibodies; Drug Resistance; Drug Therapy, Combination; Gastroenteritis; Humans; Hypereosinop	1994
Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy. The Mount Sinai journal of medicine, New York, 1999, Volume: 66, Issue:2 Topics: Anti-Inflammatory Agents; Cytomegalovirus Infections; Fatal Outcome; Humans; Immunocompromised Host;	1999
Hodgkin's disease: clinical presentation and treatment. Cancer treatment and research, 2001, Volume: 104 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined	2001
Allogeneic stem cell transplantation for Evans syndrome. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adrenal Cortex Hormones; Adult; Anemia, Hemolytic, Autoimmune; Antibodies, Monoclonal; Autoimmune Di	2001
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. Revue de pneumologie clinique, 1991, Volume: 47, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine;	1991

Article	Year
A Randomized Trial of Daily Prednisone versus Pulsed Dexamethasone in Treatment-Naïve Adult Patients with Immune Thrombocytopenia: EIS 2002 Study. Acta haematologica, 2016, Volume: 136, Issue:2 Topics: Adult; Aged; Dexamethasone; Drug Administration Schedule; Follow-Up Studies; Glucocorticoids; Humans	2016
Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology (Oxford, England), 2010, Volume: 49, Issue:1 Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combin	2010
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Addition of thalidomide to oral melphalan/prednisone in patients with multiple myeloma not eligible for transplantation: results of a randomized trial from the Turkish Myeloma Study Group. European journal of haematology, 2011, Volume: 86, Issue:1 Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cross-Over Stu	2011
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine, 2007, Dec-20, Volume: 357, Issue:25 Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cal	2007
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis and rheumatism, 1995, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;	1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis and rheumatism, 1995, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;	1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis and rheumatism, 1995, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;	1995
An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis and rheumatism, 1995, Volume: 38, Issue:5 Topics: Administration, Oral; Adult; Aged; Drug Administration Schedule; Drug Therapy, Combination; Female;	1995
A cost-effectiveness analysis of OKT3 induction therapy in cadaveric kidney transplantation. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 27, Issue:6 Topics: Anti-Infective Agents; Azathioprine; Cadaver; Cost-Benefit Analysis; Cyclosporine; Drug Costs; Graft	1996
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation, 1999, Jul-27, Volume: 68, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R	1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation, 1999, Jul-27, Volume: 68, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R	1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation, 1999, Jul-27, Volume: 68, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R	1999
A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation, 1999, Jul-27, Volume: 68, Issue:2 Topics: Acute Disease; Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Graft R	1999
Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group. Transplantation, 2001, Mar-15, Volume: 71, Issue:5 Topics: Adolescent; Child; Cyclosporine; Drug Therapy, Combination; Female; Glucocorticoids; Graft Rejection	2001
Results of a triple induction regime with tacrolimus, mycophenolate mofetil, and prednisone in renal transplantation. Transplantation proceedings, 2002, Volume: 34, Issue:1 Topics: Adrenal Cortex Hormones; Age Factors; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studi	2002
Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Annals of internal medicine, 1991, Jun-01, Volume: 114, Issue:11 Topics: Adult; Cause of Death; Combined Modality Therapy; Cyclophosphamide; Disease Susceptibility; Female;	1991
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials. Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3 Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica	1988

Article	Year
The Risk of Opportunistic Infections and the Role of Antibiotic Prophylaxis in Patients on Checkpoint Inhibitors Requiring Steroids. Journal of the National Comprehensive Cancer Network : JNCCN, 2022, Volume: 20, Issue:7 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Carcinoma, Non-Small-Cell Lung; Humans; Immunocomprom	2022
[Cutaneous Scedosporium apiospermum infection in a patient on long-term systemic corticosteroids]. Annales de dermatologie et de venereologie, 2019, Volume: 146, Issue:11 Topics: Aged, 80 and over; Dermatomycoses; Glucocorticoids; Hand; Humans; Immunocompromised Host; Male; Myco	2019
Incidental COVID-19 in a heart-kidney transplant recipient with malnutrition and recurrent infections: Implications for the SARS-CoV-2 immune response. Transplant infectious disease : an official journal of the Transplantation Society, 2020, Volume: 22, Issue:6 Topics: Antibiotics, Antineoplastic; Bacteremia; BK Virus; Cardiomyopathy, Dilated; Cardiotoxicity; COVID-19	2020
Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study. Cancer medicine, 2021, Volume: 10, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Beijing; Female; Glucocorticoids; Humans; Immune Checkpoint Inhibito	2021
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients. JAAPA : official journal of the American Academy of Physician Assistants, 2021, Feb-01, Volume: 34, Issue:2 Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromis	2021
Disseminated Nocardiosis Associated with Treatment with Infliximab in a Patient with Ulcerative Colitis. The American journal of case reports, 2017, Dec-21, Volume: 18 Topics: Colitis, Ulcerative; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agen	2017
Disseminated nocardiosis with cerebral and subcutaneous lesions on low-dose prednisone. Practical neurology, 2019, Volume: 19, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Brain; Humans; Immunocompromised Host; Male; Nocardia Infections; Op	2019
A case of severe cutaneous BMJ case reports, 2019, Jan-10, Volume: 12, Issue:1 Topics: Aged; Animals; Anti-Bacterial Agents; Crohn Disease; Fishes; Humans; Male; Mycobacterium Infections,	2019
Invasive fungal infections in renal transplant recipients: about 11 cases. Journal de mycologie medicale, 2013, Volume: 23, Issue:4 Topics: Adult; Anti-Bacterial Agents; Coinfection; Female; Graft Rejection; Humans; Immunocompromised Host;	2013
Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia. Klinische Padiatrie, 2014, Volume: 226, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; Chil	2014
[Chronic ulcer in nasal vestibule]. Medicina clinica, 2014, Jul-07, Volume: 143, Issue:1 Topics: Chronic Disease; Diagnosis, Differential; Female; Granuloma, Lethal Midline; Humans; Immunocompromis	2014
Opportunistic infections in patients with pemphigus. Journal of the American Academy of Dermatology, 2014, Volume: 71, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus	2014
Aggressive Cunninghamella pneumonia in an adolescent. Journal of pediatric hematology/oncology, 2014, Volume: 36, Issue:7 Topics: Adolescent; Anti-Inflammatory Agents; Cunninghamella; Humans; Hyperbilirubinemia; Male; Mucormycosis	2014
Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients. Pharmacotherapy, 2015, Volume: 35, Issue:8 Topics: Adult; Animals; Antilymphocyte Serum; Blood Cell Count; Drug Therapy, Combination; Female; Graft Rej	2015
[Pulmonary nodules in a patient on long-term steroid treatment]. Praxis, 2008, Jul-30, Volume: 97, Issue:15 Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Mycobacterium Infect	2008
[Pneumocystis pneumonia among patients with systemic diseases]. Presse medicale (Paris, France : 1983), 2009, Volume: 38, Issue:2 Topics: Adrenal Cortex Hormones; Arthritis, Rheumatoid; Cyclophosphamide; Drug Therapy, Combination; Granulo	2009
[Mycobacterium neoaurum bacteremia in an immunodepressed patient]. Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:1 Topics: Adult; Azathioprine; Bacteremia; Colitis, Ulcerative; Female; Humans; Immunocompromised Host; Immuno	2009
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry. Annals of the rheumatic diseases, 2010, Volume: 69, Issue:2 Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Epidemiologic M	2010
Central airways obstruction due to Aspergillus fumigatus after lung transplantation. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2009, Volume: 28, Issue:5 Topics: Airway Obstruction; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Diagnosis, Differential;	2009
Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment. JAMA, 2009, Jun-24, Volume: 301, Issue:24 Topics: Anti-Infective Agents; Antifungal Agents; Glucocorticoids; Humans; Immunocompromised Host; Leukemia,	2009
Swine H1N1 influenza in a post liver transplant patient. The New Zealand medical journal, 2009, Oct-09, Volume: 122, Issue:1304 Topics: Adult; Antiviral Agents; Critical Care; Diagnosis, Differential; Disease Outbreaks; Drug Resistance,	2009
Atypical presentation of histoplasmosis in a patient with psoriasis and psoriatic arthritis on infliximab therapy. Journal of drugs in dermatology : JDD, 2010, Volume: 9, Issue:1 Topics: Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Therapy, Combina	2010
Primary cytomegalovirus infection with accompanying Pneumocystis jiroveci pneumonia in a patient with large-vessel vasculitis. Infection, 2010, Volume: 38, Issue:4 Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosup	2010
Borreliosis in a patient treated with anti-TNFα therapy: first case. Journal of the European Academy of Dermatology and Venereology : JEADV, 2011, Volume: 25, Issue:3 Topics: Anti-Bacterial Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Doxycycline; Drug Therapy, Combi	2011
[Rash, fever, eosinophilia and elevated liver enzymes. DRESS syndrome (drug reaction or rash with eosinophilia and systemic symptoms)]. Praxis, 2010, Jun-23, Volume: 99, Issue:13 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy	2010
Kaposi's sarcoma: an opportunistic infection by human herpesvirus-8 in ulcerative colitis. Journal of Crohn's & colitis, 2010, Volume: 4, Issue:5 Topics: Aged; Colitis, Ulcerative; Colonic Neoplasms; Herpesvirus 8, Human; Humans; Immunocompromised Host;	2010
Crusted Norwegian scabies, an opportunistic infection, with tocilizumab in rheumatoid arthritis. Joint bone spine, 2011, Volume: 78, Issue:4 Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Arthr	2011
PCP chemoprophylaxis is essential for lymphopenic dermatomyositis patients treated with immunomodulators. Muscle & nerve, 2011, Volume: 43, Issue:6 Topics: Chemoprevention; Dermatomyositis; Humans; Inflammation Mediators; Lymphopenia; Male; Middle Aged; Op	2011
Cerebellar Cladophialophora bantiana infection in a patient with marginal zone lymphoma treated with immunochemotherapy including rituximab. British journal of haematology, 2011, Volume: 154, Issue:4 Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Central Nerv	2011
Cutaneous fusariosis developing in a post-irradiation site. Dermatology online journal, 2011, May-15, Volume: 17, Issue:5 Topics: Adult; Combined Modality Therapy; Cyclosporine; Debridement; Dermatomycoses; Female; Fusarium; Human	2011
Nocardia infection in a renal transplant recipient. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2011, Volume: 22, Issue:6 Topics: Acetamides; Anti-Infective Agents; Antifungal Agents; Cyclosporine; Drug Therapy, Combination; Epidu	2011
Pneumocystis pneumonia in patients with immunobullous dermatoses. International journal of dermatology, 2011, Volume: 50, Issue:9 Topics: Aged; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middl	2011
Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy. Annals of hematology, 2013, Volume: 92, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols;	2013
Fatal invasive aspergillosis of the larynx. European journal of haematology, 2013, Volume: 90, Issue:4 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Aspergillosis; Consolidation Chemother	2013
Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2002, Volume: 8, Issue:7 Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Child; Child, Preschool; Female; Graft v	2002
[Atypical cytomegalovirus in renal transplantation: a new form of presentation]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2002, Volume: 22, Issue:4 Topics: Aged; Cytomegalovirus; Cytomegalovirus Infections; Disease Susceptibility; Duodenal Ulcer; Gastroint	2002
Nocardiosis presenting as an anterior mediastinal mass in a patient with sarcoidosis. The Mount Sinai journal of medicine, New York, 2002, Volume: 69, Issue:5 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Mediastinal Diseases; Nocardia Infections; Opportun	2002
Pneumocystis carinii in a patient with hypercalcemia and renal failure secondary to sarcoidosis. Wiener klinische Wochenschrift, 2002, Sep-30, Volume: 114, Issue:17-18 Topics: CD4 Lymphocyte Count; Drug Therapy, Combination; Humans; Hypercalcemia; Immune Tolerance; Male; Midd	2002
[Pancytopenia after viral infection in St. n. malignant lymphoma]. Praxis, 2003, Jan-22, Volume: 92, Issue:4 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality The	2003
Peripheral blood lymphocyte subset counts in patients with dermatomyositis: clinical correlations and changes following therapy. Medicine, 2003, Volume: 82, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes;	2003
Disseminated cytomegalovirus disease as a cause of prolonged fever in a bullous pemphigoid patient under systemic steroid therapy. The Journal of dermatology, 2003, Volume: 30, Issue:4 Topics: Aged; Biopsy, Needle; Cytomegalovirus Infections; Fever; Follow-Up Studies; Ganciclovir; Humans; Imm	2003
Ambivalence of CD4 lymphocytopenia in sarcoidosis. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2003, Volume: 20, Issue:1 Topics: Adult; Bronchoalveolar Lavage Fluid; Female; Glucocorticoids; Humans; Male; Opportunistic Infections	2003
Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. Postgraduate medical journal, 2004, Volume: 80, Issue:942 Topics: Anti-Infective Agents; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Dyspnea; Fatal	2004
[Invasive infection by Aspergillus terreus treated successfully with liposomal amphotericin B]. Anales de medicina interna (Madrid, Spain : 1984), 2004, Volume: 21, Issue:1 Topics: Aged; Amphotericin B; Antifungal Agents; Antiphospholipid Syndrome; Aspergillosis; Aspergillus; Auto	2004
Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. Thorax, 2004, Volume: 59, Issue:7 Topics: Anti-Inflammatory Agents; Azathioprine; Crohn Disease; Diagnosis, Differential; Humans; Immunocompro	2004
Disseminated histoplasmosis presenting as pancytopenia in a methotrexate-treated patient. American journal of hematology, 2004, Volume: 77, Issue:1 Topics: Aged; Arthritis, Rheumatoid; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Male; Met	2004
Cutaneous nocardiosis complicating management of Crohn's disease with infliximab and prednisone. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004, Oct-26, Volume: 171, Issue:9 Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Biopsy, Needle; Crohn Disease; Drug Therapy, Combinat	2004
[Endogenous Candida endophthalmitis combined with severe general diseases]. Klinische Monatsblatter fur Augenheilkunde, 2005, Volume: 222, Issue:3 Topics: Aged; Amphotericin B; Anterior Chamber; Antifungal Agents; Candidiasis; Endophthalmitis; Female; Fun	2005
Fungal infections as a complication of therapy for sarcoidosis. QJM : monthly journal of the Association of Physicians, 2005, Volume: 98, Issue:6 Topics: Antifungal Agents; Cryptococcosis; Humans; Immunocompromised Host; Immunosuppressive Agents; Methotr	2005
Could Candida dubliniensis be involved in lung fungus balls? Revista iberoamericana de micologia, 2005, Volume: 22, Issue:3 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bronchoalveolar Lavage Fluid; Candida; C	2005
Mycophenolate mofetil in dermatomyositis: is it safe? Neurology, 2006, Apr-25, Volume: 66, Issue:8 Topics: Adult; Aged; Bronchopneumonia; Dermatomyositis; Drug Administration Schedule; Drug Therapy, Combinat	2006
[Cutaneous leishmaniasis in polymyositis]. La Revue de medecine interne, 2006, Volume: 27, Issue:7 Topics: Adult; Animals; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Immunoglobulins, Intraven	2006
[Cryptococcal disease and immunosuppressive treatment]. Enfermedades infecciosas y microbiologia clinica, 2006, Volume: 24, Issue:9 Topics: Aged, 80 and over; Disease Susceptibility; Female; HIV Seronegativity; Humans; Immunocompromised Hos	2006
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis after anti-TNF-alpha therapy. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2007, Volume: 13, Issue:3 Topics: Adalimumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents	2007
Phaeohyphomycosis and Mycobacterium fortuitum abscesses in a patient receiving corticosteroids for sarcoidosis. Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:2 Pt 1 Topics: Abscess; Adult; Dermatomycoses; Female; Humans; Immunocompromised Host; Mycobacterium Infections, No	1995
Invasive aspergillosis. A complication of treatment of temporal arteritis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 1995, Volume: 15, Issue:1 Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Brain; Fatal Outcome; Female; Giant C	1995
Bacterial esophagitis associated with CD4+ T-lymphocytopenia without HIV infection. Possible role of corticosteroid treatment. Digestive diseases and sciences, 1995, Volume: 40, Issue:1 Topics: Aged; Aged, 80 and over; Bacterial Infections; Esophagitis; Female; Humans; Immunocompromised Host;	1995
Pneumocystis carinii pneumonia after liver transplantation in adults. Clinical transplantation, 1994, Volume: 8, Issue:6 Topics: Adult; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Diseases; Liver Function Te	1994
Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis. American journal of respiratory and critical care medicine, 1995, Volume: 151, Issue:3 Pt 1 Topics: Female; Granulomatosis with Polyangiitis; Humans; Immunosuppression Therapy; Immunosuppressive Agent	1995
Fatal invasive aspergillosis during cyclosporine and steroids treatment for Crohn's disease. Digestive diseases and sciences, 1995, Volume: 40, Issue:3 Topics: Adult; Aspergillosis; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Fatal Outcome; Female;	1995
[Eosinophilic endomyocarditis post partum or pregnancy-related cardiomyopathy]. Herz, 1994, Volume: 19, Issue:3 Topics: Adult; Azathioprine; Biopsy; Combined Modality Therapy; Cytomegalovirus Infections; Diagnosis, Diffe	1994
Late listeriosis after fludarabine plus prednisone treatment. British journal of haematology, 1994, Volume: 87, Issue:2 Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Fatal Outcome; Humans;	1994
Development of panhypogammaglobulinaemia in a patient with systemic lupus erythematosus. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1994, Volume: 9, Issue:6 Topics: Administration, Oral; Adult; Agammaglobulinemia; Azathioprine; Bacterial Infections; Cyclophosphamid	1994
[Cutaneous Alternaria infection occurring in the course of a treated pemphigus]. Annales de pathologie, 1994, Volume: 14, Issue:3 Topics: Aged; Alternaria; Dermatomycoses; Humans; Male; Opportunistic Infections; Pemphigus; Prednisone	1994
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1994, Volume: 45, Issue:5 Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma	1994
[Lupus erythematosus disseminatus and Pneumocystis carinii pneumonia]. Revista medica de Chile, 1993, Volume: 121, Issue:12 Topics: Bronchoalveolar Lavage Fluid; Cyclophosphamide; Female; Humans; Lung; Lupus Erythematosus, Systemic;	1993
Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. The Journal of rheumatology, 1994, Volume: 21, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Connective Tissue Diseases; Cyclophosphamide; Female; Humans; Immuno	1994
De novo hypertension after liver transplantation. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 22, Issue:2 Topics: Adult; Azathioprine; Cyclosporine; Humans; Hypertension; Immunosuppression Therapy; Labetalol; Liver	1993
Wegener granulomatosis in children and adolescents: clinical presentation and outcome. The Journal of pediatrics, 1993, Volume: 122, Issue:1 Topics: Adolescent; Adult; Age Factors; Child; Cyclophosphamide; Eye Diseases; Female; Follow-Up Studies; Gl	1993
Cutaneous phaeohyphomycosis due to Alternaria alternata responding to itraconazole. Clinical and experimental dermatology, 1993, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Alternaria; Dermatomycoses; Hand Dermatoses; Humans; Male; Nephrotic Syndro	1993
Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris. Clinical and experimental dermatology, 1996, Volume: 21, Issue:4 Topics: Aged; Glucocorticoids; Humans; Keratitis, Herpetic; Male; Opportunistic Infections; Pemphigus; Predn	1996
Opportunistic infections in patients with temporal arteritis treated with corticosteroids. Journal of the American Geriatrics Society, 1997, Volume: 45, Issue:3 Topics: Aged; Anti-Inflammatory Agents; Bacteremia; Cryptococcosis; Fatal Outcome; Giant Cell Arteritis; Hum	1997
Identification of HHV-8 DNA in the skin lesions of Kaposi's sarcoma in an immunosuppressed patient with bullous pemphigoid. Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:5 Pt 2 Topics: Aged; Aged, 80 and over; Azathioprine; DNA, Viral; Female; Herpesvirus 8, Human; Humans; Immunosuppr	1997
Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone marrow transplantation, 1997, Volume: 20, Issue:10 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation	1997
Disseminated Rhodococcus equi and Nocardia farcinica infection in a patient with sarcoidosis. The Journal of infection, 1998, Volume: 36, Issue:1 Topics: Actinomycetales Infections; Glucocorticoids; HIV Seronegativity; Humans; Immunocompromised Host; Mal	1998
Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest, 1998, Volume: 113, Issue:5 Topics: Anti-Infective Agents; Antifungal Agents; Drug Therapy, Combination; Female; Glucocorticoids; HIV In	1998
Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:5 Topics: Adult; Amphotericin B; Antifungal Agents; Azathioprine; Bone Marrow Cells; Drug Carriers; Drug Thera	1998
Nocardiosis in a recently transplanted renal patient. Clinical nephrology, 1998, Volume: 50, Issue:2 Topics: Diabetes Complications; Female; Graft Rejection; Humans; Immunosuppression Therapy; Immunosuppressiv	1998
Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Annals of internal medicine, 1998, Oct-01, Volume: 129, Issue:7 Topics: Analysis of Variance; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combine	1998
Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study. Clinical transplantation, 1998, Volume: 12, Issue:5 Topics: Adult; Azathioprine; Case-Control Studies; Cyclosporine; Cytomegalovirus Infections; Female; Humans;	1998
Disseminated histoplasmosis and Wegener's granulomatosis. Southern medical journal, 1998, Volume: 91, Issue:12 Topics: Adult; Cyclophosphamide; Fatal Outcome; Female; Glucocorticoids; Granulomatosis with Polyangiitis; H	1998
Clinical conference on management dilemmas: progressive pneumonia in a patient receiving long-term steroid therapy. Chest, 1999, Volume: 115, Issue:1 Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Biopsy; Diagnosis, Differential; Drug Therapy	1999
Primary subcutaneous nocardial infection in a SLE patient. Lupus, 1999, Volume: 8, Issue:2 Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Immunocompromised Host; Lupus Erythematosus, System	1999
[Subcutaneous mycosis due to Scopulariopsis brevicaulis in an immunocompromised patient]. Annales de dermatologie et de venereologie, 2001, Volume: 128, Issue:2 Topics: Biopsy; Cyclosporine; Dermatomycoses; Humans; Immunocompromised Host; Immunosuppressive Agents; Live	2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation. Bone marrow transplantation, 2001, Volume: 28, Issue:9 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillo	2001
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-2001. Acute febrile respiratory illness in a 57-year-old man with recurrent pulmonary disorders. The New England journal of medicine, 2001, Nov-22, Volume: 345, Issue:21 Topics: Anti-Inflammatory Agents; Cough; Cryptogenic Organizing Pneumonia; Diagnosis, Differential; Fever; H	2001
Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma. International journal of hematology, 2002, Volume: 75, Issue:1 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; CD4-Positive	2002
Failure of G-CSF therapy in neutropenia associated with Sjögren's syndrome. Rheumatology (Oxford, England), 2002, Volume: 41, Issue:4 Topics: Amikacin; Anemia; Anti-Bacterial Agents; Female; Filgrastim; Granulocyte Colony-Stimulating Factor;	2002
Complications of corticosteroid therapy in presumptive temporal arteritis. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1976, Volume: 11, Issue:2 Topics: Aged; Autopsy; Biopsy; Female; Giant Cell Arteritis; Humans; Male; Opportunistic Infections; Prednis	1976
Cytomegalovirus infection in children with blood diseases. Acta haematologica Polonica, 1992, Volume: 23, Issue:3 Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; C	1992
Pneumonia and pneumonitis in childhood malignancy. Acta paediatrica (Oslo, Norway : 1992), 1992, Volume: 81, Issue:3 Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bacterial Infections; C	1992
Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. The American journal of medicine, 1992, Volume: 93, Issue:1 Topics: Aged; Aged, 80 and over; Aspergillosis; Aspergillus fumigatus; Asthma; Female; Forced Expiratory Vol	1992
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2 Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin	1991
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Wegener granulomatosis: an analysis of 158 patients. Annals of internal medicine, 1992, Mar-15, Volume: 116, Issue:6 Topics: Adolescent; Adult; Aged; Biopsy; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-	1992
Salmonella arizona arthritis and septicemia associated with rattlesnake ingestion by patients with connective tissue diseases. A dangerous complication of folk medicine. The Journal of rheumatology, 1991, Volume: 18, Issue:9 Topics: Adolescent; Adult; Animals; Arthritis, Infectious; Azathioprine; Connective Tissue Diseases; Drug Th	1991
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy. Archives of dermatology, 1990, Volume: 126, Issue:1 Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle	1990
Multiple brain abscesses from isolated cerebral mucormycosis. Journal of neurology, neurosurgery, and psychiatry, 1990, Volume: 53, Issue:5 Topics: Adult; Brain Abscess; Cyclophosphamide; Female; Frontal Lobe; Humans; Lupus Erythematosus, Systemic;	1990
Sequential antilymphocyte globulin/cyclosporine immunosuppression in cadaveric renal transplantation. Effect of duration of ALG therapy. Transplantation, 1989, Volume: 47, Issue:1 Topics: Antilymphocyte Serum; Azathioprine; Cadaver; Cyclosporins; Drug Administration Schedule; Graft Rejec	1989
Serious infectious complications of corticosteroid therapy for COPD. Chest, 1989, Volume: 95, Issue:6 Topics: Aged; Aged, 80 and over; Female; Humans; Lung Diseases, Obstructive; Male; Methylprednisolone; Middl	1989
Pulmonary infections in renal transplantation patients treated with cyclosporine. Radiology, 1988, Volume: 167, Issue:1 Topics: Adult; Cyclosporins; Cytomegalovirus Infections; Female; Humans; Kidney Transplantation; Male; Middl	1988
A prospective study on infection with cytomegalovirus in renal allograft recipients immunosuppressed with cyclosporine A and low dose prednisone. Scandinavian journal of infectious diseases, 1987, Volume: 19, Issue:3 Topics: Adolescent; Adult; Antibodies, Viral; Child; Cyclosporins; Cytomegalovirus; Cytomegalovirus Infectio	1987
First month cyclosporine A sparing in renal transplantation. Transplantation proceedings, 1988, Volume: 20, Issue:3 Suppl 3 Topics: Creatinine; Cyclosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Graft Reje	1988

prednisone and Opportunistic Infections